% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • jcmoneystox jcmoneystox May 7, 2013 6:50 PM Flag

    Eerily similar to PPHM

    I'm not a shareholder. Never have been. I'm really only interested in PPHM, but know SNTA because they're in the 2nd line NSCLC space. For those who know the story, PPHM, too had a 2nd line NSCLC trial for their lead drug candidate in combination with docetaxel. Well, last fall someone at a CRO switched the labels on the vials between a treatment arm and placebo and blew the whole trial up. Stock dropped 84% in one day. Luckily, they've bounced back but the company verified there was "clear evidence" that someone purposefully switched the dose labeling. However, it was at about this point in their trial that they announced the error. About 3 weeks prior to a huge conference in Europe. When some of us investors found out the conference was cancelled, investor relations said it was due to personal reasons that management could not attend. Keep an eye out for any sign of the ASCO abstract being pulled and if you see it, run don't walk for the exit. Good luck.

    SortNewest  |  Oldest  |  Most Replied Expand all replies